Status:
COMPLETED
Identification and Treatment of Cervical Abnormalities in Perú Through Integration of Pocket Colposcopy and Telemedicine
Lead Sponsor:
Duke University
Collaborating Sponsors:
United States Agency for International Development (USAID)
Universidad Peruana Cayetano Heredia
Conditions:
Cervical Cancer
HPV Infection
Eligibility:
FEMALE
30-49 years
Phase:
NA
Brief Summary
The Pocket colposcope has 510k FDA clearance and has been successfully used in almost 1500 unique patients globally in Duke and non-Duke protocols to date. The objective is to provide colposcopy capab...
Detailed Description
The goal is to demonstrate that the combination of self-sampling, the Pocket colposcope and the thermocoagulator will yield a high proportion of HPV positive women who complete treatment and follow-up...
Eligibility Criteria
Inclusion
- HPV+ pap smear
- Women must between the ages of 30-49yo
Exclusion
- HPV (-) pap smear
- people without a cervix
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2023
Estimated Enrollment :
503 Patients enrolled
Trial Details
Trial ID
NCT05340322
Start Date
May 1 2022
End Date
October 15 2023
Last Update
July 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad Peruana Cayetano Heredia
Lima, Peru